Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

NEA News

NEA celebrates another win for access to new atopic dermatitis therapy Dupixent

ICER, a nonprofit that conducts independent reviews on clinical effectiveness and value of treatments, found Dupixent to be a “high value” drug for adults with atopic dermatitis.

Read More


Celebrate the Individual Gifts that Your Child Has

Joanna Dobos is the mother of 4 sons who have severe eczema. While her children face various challenges in managing their eczema symptoms, she has also focused on their self-esteem.

Read More


American Academy of Dermatology 2017 Annual Meeting Wrap-Up

Each year, thousands of doctors, scientists, students, industry and patient advocacy groups like National Eczema Association, gather to hear the latest research and standards of medical care in dermatology at the American Academy of Dermatology (AAD) Annual Meeting. Photo Credit Dermatology World Atopic dermatitis is a hot field of study. Here’s some highlights from this […]

Read More


Hope with new AD drugs but will they be covered?

There are dozens of new drugs in development for atopic dermatitis (AD). Late last year, the Food and Drug Administration (FDA) approved the non-steroidal topical treatment, Eucrisa for mild to moderate atopic dermatitis. This March, the FDA is expected to approve dupilumab, the first biologic drug for adults with moderate to severe AD. As more […]

Read More


2017 NEA Research Grants Focus on Sleep and Pain

To find out more about why and how pain and sleep problems affect people with atopic dermatitis, the National Eczema Association funded three studies in these areas as part of its 2017 Research Grant Program.

Read More


Shining a Light on the Seriousness of Atopic Dermatitis and New Treatment Options

For the first time, ever, the Institute for Clinical and Economic Review (ICER) has begun a process to review the clinical effectiveness and value of two new treatments for atopic dermatitis (AD). ICER is an independent, nonprofit organization that evaluates treatments for serious diseases such as cancer, multiple sclerosis and psoriasis, and develops recommendations about […]

Read More


Eczema is a Real Character

The HBO mini-series called “The Night Of” is about a complicated murder case set in New York City. It’s about the transformation of a young Pakistani-American man from a “nice guy” to a Riker’s Island criminal. It’s also about eczema. And how this condition can affect every part of a person’s life. Actor John Turturro […]

Read More


According to a new Understand AD survey of 505 American adults (18 years of age and older) who self-reported being diagnosed with moderate-to-severe atopic dermatitis, results show that the disease goes beyond physical signs and symptoms and negatively impacts their lives socially and psychologically. The results, unveiled during Eczema Awareness Month, show that a majority […]

Read More


In Your Words: The Parent Perspective

Did you know that 1 in 10 children in the US have eczema? With so many children struggling to live with eczema, we wanted to hear from our members how eczema directly impacts the quality of life of their school-age children, and their entire family. So this past August, we asked NEA parents and caregivers to reply […]

Read More


October 17, 2016 – NEA wants to hear from you! If you are a parent or caregiver of a child under 18, we invite you to participate in this survey to help us better understand your interest and preferences in drug development for children with eczema. The information you provide will inform a guidance document that will […]

Read More